View in EDS HTML Full Text PDF Full Text

Early use of high-efficacy disease-modifying therapies reduces the risk of progression independent of relapse and MRI activity in patients with relapsing-remitting multiple sclerosis.

Saved in:
Bibliographic Details
Title: Early use of high-efficacy disease-modifying therapies reduces the risk of progression independent of relapse and MRI activity in patients with relapsing-remitting multiple sclerosis.
Authors: Guarnaschelli MF; Department of Neurology, Fleni, Buenos Aires, Argentina., Marrodan M; Department of Neurology, Fleni, Buenos Aires, Argentina., Sosa BE; Department of Neurology, Fleni, Buenos Aires, Argentina., Perez Arana CI; Department of Neurology, Fleni, Buenos Aires, Argentina., Farez MF; Department of Neurology, Fleni, Buenos Aires, Argentina., Fiol MP; Department of Neurology, Fleni, Buenos Aires, Argentina., Ysrraelit MC; Department of Neurology, Fleni, Buenos Aires, Argentina., Correale J; Department of Neurology, Fleni, Buenos Aires, Argentina; IQUIFIB, School of Pharmacy and Biochemistry, University of Buenos Aires, Buenos Aires, Argentina.
Source: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2026 Jun; Vol. 32 (7), pp. 737-746. Date of Electronic Publication: 2026 Apr 29.
Publication Type: Journal Article; Observational Study
Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42057337
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Early use of high-efficacy disease-modifying therapies reduces the risk of progression independent of relapse and MRI activity in patients with relapsing-remitting multiple sclerosis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Guarnaschelli+MF%22">Guarnaschelli MF</searchLink>; Department of Neurology, Fleni, Buenos Aires, Argentina.<br /><searchLink fieldCode="AU" term="%22Marrodan+M%22">Marrodan M</searchLink>; Department of Neurology, Fleni, Buenos Aires, Argentina.<br /><searchLink fieldCode="AU" term="%22Sosa+BE%22">Sosa BE</searchLink>; Department of Neurology, Fleni, Buenos Aires, Argentina.<br /><searchLink fieldCode="AU" term="%22Perez+Arana+CI%22">Perez Arana CI</searchLink>; Department of Neurology, Fleni, Buenos Aires, Argentina.<br /><searchLink fieldCode="AU" term="%22Farez+MF%22">Farez MF</searchLink>; Department of Neurology, Fleni, Buenos Aires, Argentina.<br /><searchLink fieldCode="AU" term="%22Fiol+MP%22">Fiol MP</searchLink>; Department of Neurology, Fleni, Buenos Aires, Argentina.<br /><searchLink fieldCode="AU" term="%22Ysrraelit+MC%22">Ysrraelit MC</searchLink>; Department of Neurology, Fleni, Buenos Aires, Argentina.<br /><searchLink fieldCode="AU" term="%22Correale+J%22">Correale J</searchLink>; Department of Neurology, Fleni, Buenos Aires, Argentina; IQUIFIB, School of Pharmacy and Biochemistry, University of Buenos Aires, Buenos Aires, Argentina.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229509185%22">Multiple sclerosis (Houndmills, Basingstoke, England)</searchLink> [Mult Scler] 2026 Jun; Vol. 32 (7), pp. 737-746. <i>Date of Electronic Publication: </i>2026 Apr 29.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Observational Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22SAGE+Publications%22">SAGE Publications </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9509185 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1477-0970 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213524585%22">13524585 </searchLink><i>NLM ISO Abbreviation: </i>Mult Scler <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42057337
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/13524585261442036
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 737
    Titles:
      – TitleFull: Early use of high-efficacy disease-modifying therapies reduces the risk of progression independent of relapse and MRI activity in patients with relapsing-remitting multiple sclerosis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Guarnaschelli MF
      – PersonEntity:
          Name:
            NameFull: Marrodan M
      – PersonEntity:
          Name:
            NameFull: Sosa BE
      – PersonEntity:
          Name:
            NameFull: Perez Arana CI
      – PersonEntity:
          Name:
            NameFull: Farez MF
      – PersonEntity:
          Name:
            NameFull: Fiol MP
      – PersonEntity:
          Name:
            NameFull: Ysrraelit MC
      – PersonEntity:
          Name:
            NameFull: Correale J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2026 Jun
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1477-0970
          Numbering:
            – Type: volume
              Value: 32
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Multiple sclerosis (Houndmills, Basingstoke, England)
              Type: main
ResultId 1